European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Patient experience with Mim8 prophylaxis: 52-week patient-reported outcomes in adolescents and adults with haemophilia A (FRONTIER2)

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Blood Disorders
Congress poster
Mim8